Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 32
Filtrar
1.
Public Health ; 173: 5-8, 2019 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-31207425

RESUMEN

OBJECTIVE: The objective of this study was to explore factors influencing patients with hypertension to participating in a hypertension self-management education (HSME) programme and challenges of sustaining the learnt self-care practices. STUDY DESIGN: This was a qualitative study with focus group discussions. METHODS: Focus group discussions using a semistructured moderator guide were conducted among participants who had attended the HSME programme. Data were audio recorded, transcribed verbatim and analysed using a thematic analysis approach. RESULTS: Three focus groups involving 19 participants were conducted. Four major themes emerged from the data collected. Most participants enjoyed the group-based HSME sessions because sharing experiences with those having similar health problems can reduce their sense of isolation. However, the participants highlighted the difficulty in sustaining self-care practices in the presence of friends and family influences. CONCLUSION: A number of patient-, family- and community-level motivators and barriers to patients' hypertension self-management have been identified. Efforts to tailor behavioural interventions to sustain daily self-care activities during social and cultural events are imperative.


Asunto(s)
Educación en Salud , Conocimientos, Actitudes y Práctica en Salud , Hipertensión/terapia , Motivación , Educación del Paciente como Asunto , Autocuidado/psicología , Automanejo/psicología , Anciano , Femenino , Grupos Focales , Humanos , Hipertensión/psicología , Masculino , Persona de Mediana Edad , Investigación Cualitativa
2.
Value Health Reg Issues ; 15: 161-168, 2018 May.
Artículo en Inglés | MEDLINE | ID: mdl-29730249

RESUMEN

BACKGROUND: Low rate of adherence was found strongly associated with patients' beliefs across the studies about chronic diseases with hypertension. A crucial move is needed to bridge the gap between appropriate assessment tools and local hypertensive patients' medication adherence. OBJECTIVE: To produce a translated version in Malay language of Beliefs about Medicines Questionnaire (BMQ) that was "conceptually equivalent" to the original English version for use in local clinical practice and research. METHODS: The forward translation process was conducted by two independent professional translators and back translation was done by two other independent translators. A reliability analysis was conducted on 238 conveniently selected hypertensive patients. Intraclass correlation coefficient (ICC) was used to assess test-retest reliability for the randomly selected 40 patients in a period of 2 weeks. Discriminant validity was tested through Necessity-Concerns differential, BMQ subscales, and other parameters. RESULTS: The overall Cronbach alpha for the internal consistency was good (0.860). The subscales of the BMQ demonstrated adequate internal consistency, with Cronbach alpha value of 0.759 for Specific-Necessity, 0.762 for Specific Concern, 0.624 for General-Overuse, and 0.756 for General-Harm. The ICC was excellent (0.922). Discriminant validity revealed that BMQ Specific-Necessity score was significantly inversely correlated with the systolic blood pressure level. Systolic and diastolic blood pressure levels (P = 0.038; P = 0.05) were reported to be significantly correlated with the Necessity-Concerns differential, with Necessity score equal or exceeding Concerns score. CONCLUSIONS: The Malay-translated version of BMQ is a reliable and valid tool to assess patient belief about medication, especially medication adherence among the hypertensive patients in Malaysia.


Asunto(s)
Competencia Cultural , Lingüística , Cumplimiento de la Medicación/estadística & datos numéricos , Encuestas y Cuestionarios/normas , Traducciones , Enfermedad Crónica/tratamiento farmacológico , Estudios Transversales , Femenino , Humanos , Hipertensión/tratamiento farmacológico , Malasia , Masculino , Persona de Mediana Edad , Psicometría , Reproducibilidad de los Resultados
3.
Eur J Clin Microbiol Infect Dis ; 37(3): 537-544, 2018 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-29185089

RESUMEN

Micafungin was shown to be as efficacious as caspofungin in treating patients with candidaemia and invasive candidiasis (IC). However, it remains unknown if micafungin or caspofungin is a cost-effective definitive therapy for candidaemia and IC in Turkey. The present study aimed to determine the economic impact of using micafungin versus caspofungin for treatment of candidaemia and IC in the Turkish setting. A decision analytic model was constructed and was populated with data (i.e. transition probabilities, duration of initial antifungal treatment, reasons for treatment failure, percentage of patients who stepped down to oral fluconazole, and duration on oral fluconazole) obtained from a published randomised clinical trial. Cost inputs were derived from the latest Turkish resources while data that were not readily available in the literature were estimated by expert panels. One-way sensitivity analyses, threshold analyses, scenario analyses and probabilistic sensitivity analyses were conducted. Caspofungin (€2693) incurred a lower total cost than micafungin (€4422), with a net cost saving of €1729 per treated patient. Drug acquisition cost was the main cost driver for both study arms. The model outcome was robust over wide variations (of ±100.0% from the base case value) for all input parameters except for micafungin drug cost and the duration of initial treatment with micafungin. Caspofungin appears to be a cost-saving option in treating candidaemia and IC from the Turkish hospital perspective.


Asunto(s)
Antifúngicos/economía , Candidemia/tratamiento farmacológico , Equinocandinas/economía , Lipopéptidos/economía , Modelos Económicos , Antifúngicos/uso terapéutico , Candidemia/economía , Candidemia/epidemiología , Candidiasis Invasiva/tratamiento farmacológico , Candidiasis Invasiva/economía , Candidiasis Invasiva/epidemiología , Caspofungina , Análisis Costo-Beneficio , Bases de Datos Factuales , Equinocandinas/uso terapéutico , Humanos , Lipopéptidos/uso terapéutico , Micafungina , Resultado del Tratamiento , Turquía/epidemiología
4.
Eye (Lond) ; 29(9): 1162-6, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-26043705

RESUMEN

PURPOSE: To review the histopathological diagnoses, visual outcome, and complication rate of orbital biopsy in a UK tertiary referral centre. METHODS: This was a retrospective, clinical-pathological, interventional, consecutive case series. All orbital biopsies performed between July 2004 and June 2014 in Newcastle Eye Centre (Newcastle upon Tyne, UK) were included in this study. All relevant data collected from the local electronic database and medical records were analysed. RESULTS: A total of 166 orbital biopsies were identified during the study period: 86 patients (53.1%) were female and the mean age was 53.7 ± 19.7 years. Of all the cases, orbital biopsies were performed unilaterally in 158 (97.5%) patients and bilaterally in 4 (2.5%) patients. The mean follow-up period was 2.2 ± 2.3 years. The two most common histopathological diagnoses were non-specific inflammatory disease (62, 38.3%) and lymphoproliferative disease (40, 24.7%). None of the patients experienced ≥ 2-Snellen line visual loss. There were 7 (4.2%) postoperative complications noted: 1 (0.6%) orbital haemorrhage with no loss of vision, 4 (2.4%) diplopia, 1 (0.6%) short-term symblepharon, and 1 (0.6%) conjunctival granuloma. Postoperative diplopia was associated with lateral orbitotomy (P = 0.044) and excisional biopsy (P = 0.015). CONCLUSIONS: Orbital biopsy serves as a safe diagnostic tool in managing orbital diseases. Patient should be made aware of the risk of postoperative diplopia. Our data provides useful guidance to clinicians when counselling patients for orbital biopsy.


Asunto(s)
Enfermedades Orbitales/patología , Adulto , Anciano , Biopsia/métodos , Diplopía/etiología , Inglaterra , Femenino , Humanos , Masculino , Persona de Mediana Edad , Enfermedades Orbitales/fisiopatología , Complicaciones Posoperatorias/etiología , Estudios Retrospectivos , Agudeza Visual/fisiología , Adulto Joven
5.
Intern Med J ; 43(6): 668-77, 2013 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-23461421

RESUMEN

BACKGROUND: Micafungin demonstrated non-inferiority to caspofungin as definitive therapy for candidaemia and invasive candidiasis (IC) in a major randomised clinical trial. AIM: The aim of this study was to investigate if micafungin is a cost-saving option compared with caspofungin for treating candidaemia and IC. METHODS: A decision analytical model was constructed to capture downstream consequences of using either agent as initial therapy for candidaemia and IC. The main outcomes were treatment success and treatment failure (i.e. death, mycological persistence, emergent infection, clinical failure but microbiological success). Outcome probabilities and treatment pathways were derived from the literature. Cost inputs were from the latest Australian resources, and resource use was estimated by expert panel. The analysis was from the Australian hospital perspective. Sensitivity analyses using Monte Carlo simulation were conducted. RESULTS: Micafungin (AU$52 816) was associated with a lower total cost than caspofungin (AU$52 976), with a net cost-saving of $160 per patient. This was primarily due to the lower cost associated with alternative antifungal treatment in the micafungin arm. Hospitalisation was the main cost-driver for both arms. The model outcome was most sensitive to the proportion of treatment success in the micafungin arm. Uncertainty analysis demonstrated that micafungin had a 58% chance of being cost-saving compared with caspofungin. CONCLUSIONS: Micafungin was cost-equivalent to caspofungin in treating candidaemia and IC, with variation in drug acquisition cost the critical factor.


Asunto(s)
Antifúngicos/economía , Candidemia/tratamiento farmacológico , Candidemia/economía , Equinocandinas/economía , Lipopéptidos/economía , Modelos Económicos , Antifúngicos/uso terapéutico , Candidiasis Invasiva/tratamiento farmacológico , Candidiasis Invasiva/economía , Caspofungina , Análisis Costo-Beneficio/economía , Equinocandinas/uso terapéutico , Humanos , Lipopéptidos/uso terapéutico , Micafungina , Resultado del Tratamiento
6.
Transpl Infect Dis ; 15(4): 344-53, 2013 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-23527908

RESUMEN

BACKGROUND: Invasive fungal infection (IFI) is associated with high mortality in lung transplant (LTx) recipients. Data for voriconazole use in preemptive treatment remain scant. METHOD: A single-center, retrospective cohort study was conducted to investigate the efficacy and safety of voriconazole preemptive treatment for post-LTx colonization. RESULTS: We reviewed 62 adult LTx patients, who received their first course of voriconazole prophylaxis (i.e., as preemptive treatment) between July 2003 and June 2010. Outcomes were determined at 6 and 12 months after commencing therapy. Aspergillus fumigatus (75.8%) was the most common colonizing isolate. Median duration of voriconazole prophylaxis was 85 days. At 6 months, 1 LTx patient (1.6%) had IFI, 47 (75.8%) cleared their colonizing isolate, 3 (4.8%) had persistent colonization, 7 (11.3%) had recurrent colonization, 1 (1.6%) had new colonization, 2 (3.2%) had aspergilloma, and 1 (1.6%) was clinically unstable with no culture results. Sixteen (25.8%) had died by 12 months. Ten (16.1%) had likely drug-related hepatotoxicity. LTx patients with diabetes mellitus within 30 days before commencing prophylaxis were at higher risk of recurrent Aspergillus colonization at 6 months (P = 0.030). Chronic rejection within 30 days before prophylaxis was associated with 12-month mortality (P = 0.007). CONCLUSIONS: Voriconazole preemptive treatment resulted in low incidence of IFI and IFI-related mortality.


Asunto(s)
Antifúngicos/uso terapéutico , Trasplante de Pulmón/efectos adversos , Micosis/epidemiología , Micosis/mortalidad , Pirimidinas/uso terapéutico , Triazoles/uso terapéutico , Adolescente , Adulto , Anciano , Aspergillus fumigatus/efectos de los fármacos , Aspergillus fumigatus/aislamiento & purificación , Estudios de Cohortes , Femenino , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Micosis/microbiología , Micosis/prevención & control , Estudios Retrospectivos , Resultado del Tratamiento , Voriconazol , Adulto Joven
7.
Singapore Med J ; 53(2): e24-7, 2012 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-22337196

RESUMEN

Rhinoscleroma is a chronic, slowly progressive, inflammatory disease of the upper respiratory tract. It is associated with Klebsiella rhinoscleromatis infection. We present the clinical and pathological features of four patients diagnosed with rhinoscleroma at the National Skin Centre, Singapore between 1997 and 2010. All four patients presented with only cutaneous involvement, and the diagnosis was clinched via histological examination. The patients were treated with a combination of antibiotics. Two patients who were on follow-up at the time of this writing responded positively to the antibiotic treatment, while two were lost to follow-up. Rhinoscleroma is a diagnostic challenge, as it is an uncommon disease in Singapore and Malaysia. We highlight this condition to raise awareness of the disease in order to aid in early diagnosis of patients. Without treatment, this condition can result in significant complications, including involvement of the lower airways. Early diagnosis and appropriate treatment help to reduce morbidity.


Asunto(s)
Rinoscleroma/patología , Adulto , Antibacterianos/administración & dosificación , Antibacterianos/uso terapéutico , Ciprofloxacina/administración & dosificación , Ciprofloxacina/uso terapéutico , Doxiciclina/administración & dosificación , Doxiciclina/uso terapéutico , Quimioterapia Combinada , Femenino , Humanos , Persona de Mediana Edad , Nariz/patología , Rinoscleroma/diagnóstico , Rinoscleroma/epidemiología , Singapur/epidemiología
8.
Am J Transplant ; 11(2): 361-6, 2011 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-21272239

RESUMEN

While variations in antifungal prophylaxis have been previously reported in lung transplant (LTx) recipients, recent clinical practice is unknown. Our aim was to determine current antifungal prophylactic practice in LTx centers world-wide. One nominated LTx clinician from each active center was invited by e-mail to participate in a web-based survey between September 2009 and January 2010. Fifty-seven percent (58/102) responded. The majority of responses were from medical directors of LTx centers (72.4%), and from the United States (44.8%). Within the first 6 months post-LTx, most centers (58.6%) employed universal prophylaxis, with 97.1% targeting Aspergillus species. Voriconazole alone, and in combination with inhaled amphotericin B (AmB), were the preferred first-line agents. Intolerance to side effects of voriconazole (69.2%) was the main reason for switching to alternatives. Beyond 6 months post-LTx, most (51.8%) did not employ antifungal prophylaxis. Fifteen centers (26.0%) conducted routine antifungal therapeutic drug monitoring during prophylactic period. There are differences in strategies employed between U.S. and European centers. Most respondents indicated a need for antifungal prophylactic guidelines. In comparison to earlier findings, there was a major shift toward prophylaxis with voriconazole and an increased use of echinocandins, posaconazole and inhaled lipid formulation AmB.


Asunto(s)
Antifúngicos/farmacología , Trasplante de Pulmón/métodos , Micosis/prevención & control , Adulto , Recolección de Datos , Europa (Continente) , Humanos , Trasplante de Pulmón/efectos adversos , Micosis/etiología , Factores de Tiempo , Estados Unidos
9.
Osteoarthritis Cartilage ; 18(9): 1192-202, 2010 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-20510383

RESUMEN

OBJECTIVE: To study the effects of oral glucosamine sulfate on the development of osteoarthritis (OA) and to examine concomitant changes in the nociceptive behavior of rats. METHODS: OA was induced in Wistar rats by anterior cruciate ligament transection (ACLT) of the right knee; the left knee was untreated. The OA+glucosamine group received oral glucosamine sulfate (250 mg/kg/day) in a 2-g wafer once a day for 10 consecutive weeks starting at week 5 after ACLT. The OA group was treated as above with 2-g wafers (placebo). The control group of naïve rats received 2-g wafers only. The glucosamine alone group comprised naïve rats receiving glucosamine sulfate only. Nociceptive behavior (mechanical allodynia and weight-bearing distribution of hind paws) during OA development was analyzed pre- and 3, 6, 9, 12, 15, and 18 weeks post-ACLT. Macroscopic and histologic studies were then performed on the cartilage and synovia. Immunohistochemical analysis was performed to examine the effect of glucosamine on expression of mitogen-activated protein kinases (MAPKs) in the articular cartilage chondrocytes. RESULTS: OA rats receiving glucosamine showed a significantly lower degree of cartilage degeneration than the rats receiving placebo. Glucosamine treatment also suppressed synovitis. Mechanical allodynia and weight-bearing distribution studies showed significant improvement in the OA+glucosamine group as compared to the OA group. Moreover, glucosamine attenuated p38 and c-Jun N-terminal kinase (JNK) but increased extracellular signal-regulated kinase 1/2 (ERK) expression in OA-affected cartilage. CONCLUSION: Our results indicate that treatment with oral glucosamine sulfate in a rat OA model (1) attenuates the development of OA, (2) concomitantly reduces nociception, and (3) modulates chondrocyte metabolism, possibly through inhibition of cell p38 and JNK and increase of ERK expression.


Asunto(s)
Cartílago Articular/patología , Condrocitos/efectos de los fármacos , Condrocitos/enzimología , Glucosamina/farmacología , Proteínas Quinasas Activadas por Mitógenos/metabolismo , Osteoartritis de la Rodilla/patología , Administración Oral , Animales , Conducta Animal/efectos de los fármacos , Cartílago Articular/efectos de los fármacos , Modelos Animales de Enfermedad , Lateralidad Funcional/efectos de los fármacos , Inmunohistoquímica , Articulación de la Rodilla/patología , Nociceptores/efectos de los fármacos , Osteoartritis de la Rodilla/tratamiento farmacológico , Dimensión del Dolor/métodos , Ratas , Ratas Wistar , Membrana Sinovial/patología , Soporte de Peso/fisiología
10.
Eur J Cancer Care (Engl) ; 19(4): 551-3, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-19686354

RESUMEN

Mesenchymal chondrosarcoma is a rare tumour with orbital involvement being an exceptional occurrence. We present a case of a 22-year old man with such disease, together with details of his management. A brief literature review of this uncommon tumour was also enclosed.


Asunto(s)
Condrosarcoma Mesenquimal/terapia , Neoplasias Orbitales/terapia , Neoplasias Óseas/patología , Condrosarcoma Mesenquimal/patología , Terapia Combinada/métodos , Humanos , Masculino , Estadificación de Neoplasias , Neoplasias Orbitales/patología , Resultado del Tratamiento , Adulto Joven
11.
Clin Exp Dermatol ; 35(3): 300-4, 2010 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-19663842

RESUMEN

BACKGROUND: Pityriasis rosea (PR) is a common cutaneous papulosquamous disorder affecting young adults. Previous studies have suggested possibilities of a viral aetiology and the involvement of cell-mediated immunity, but these remain unproven to date. AIM: To elucidate the possible pathomechanisms in PR by characterizing the inflammatory cellular infiltrate in herald patches and fully developed PR eruptions. METHODS: In total, 12 biopsy specimens from 6 patients diagnosed with PR were examined. For each patient, biopsies were taken from both a herald patch and a secondary patch. Specimens were processed for histopathological examination and immunohistochemical staining with a large panel of monoclonal antibodies. RESULTS: Histopathologically, all specimens showed epidermal changes such as parakeratosis, orthokeratosis, epidermal hyperplasia and spongiosis. Less common results included epidermal exocytosis and focal parakeratosis. In all biopsies, the dermal infiltrate of lymphocytes stained positively for monoclonal antibodies specific for T cells. The ratio of the CD4+ (helper) vs. CD8+ (cytotoxic) T cells in the dermal infiltrate was increased in most specimens. Increased staining for Langerhans cells was seen within the dermis of lesional skin. There were no marked differences found in histopathology and immunohistochemistry between the herald patch and secondary lesions. Overall, there was a lack of natural killer cell and B-cell activities in PR lesions. CONCLUSIONS: Our results support a predominantly T-cell mediated immunity in the development of PR.


Asunto(s)
Inmunidad Celular/inmunología , Células de Langerhans/inmunología , Pitiriasis Rosada/inmunología , Linfocitos T/inmunología , Adolescente , Adulto , Biopsia , Femenino , Humanos , Células de Langerhans/patología , Masculino , Persona de Mediana Edad , Pitiriasis Rosada/patología , Linfocitos T/patología , Factores de Tiempo , Adulto Joven
12.
Br J Ophthalmol ; 93(11): 1518-23, 2009 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-19028743

RESUMEN

AIM: To compare the outcome of various surgical approaches of orbital decompression in patients with Graves' orbitopathy (GO) receiving surgery for disfiguring proptosis. METHOD: Data forms and questionnaires from consecutive, euthyroid patients with inactive GO who had undergone orbital decompression for disfiguring proptosis in 11 European centres were analysed. RESULTS: Eighteen different (combinations of) approaches were used, the swinging eyelid approach being the most popular followed by the coronal and transconjunctival approaches. The average proptosis reduction for all decompressions was 5.0 (SD 2.1) mm. After three-wall decompression the proptosis reduction was significantly greater than after two-wall decompression. Additional fat removal resulted in greater proptosis reduction. Complications were rare, the most frequent being worsening of motility, occurring more frequently after coronal decompression. The average change in quality of life (QOL) in the appearance arm of the GO-QOL questionnaire was 20.5 (SD 24.8) points. CONCLUSIONS: In Europe, a wide range of surgical approaches is used to reduce disfiguring proptosis in patients with GO. The extent of proptosis reduction depends on the number of walls removed and whether or not fat is removed. Serious complications are infrequent. Worsening of ocular motility is still a major complication, but was rare in this series after the swinging eyelid approach.


Asunto(s)
Descompresión Quirúrgica/métodos , Oftalmopatía de Graves/cirugía , Órbita/cirugía , Adolescente , Adulto , Anciano , Descompresión Quirúrgica/efectos adversos , Diplopía/etiología , Femenino , Oftalmopatía de Graves/fisiopatología , Humanos , Tiempo de Internación , Masculino , Persona de Mediana Edad , Calidad de Vida , Resultado del Tratamiento , Agudeza Visual/fisiología , Adulto Joven
13.
Clin Exp Dermatol ; 32(5): 539-40, 2007 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-17524069

RESUMEN

We report the case of a 56-year-old Chinese woman with phaeohyphomycosis. She presented with a 4-year history of a recurring erythematous plague initially diagnosed as chromoblastomycosis on histopathological examination. Surgical excision was performed when the lesion recurred despite intial treatment response to itraconazole. Tissue cultures of the surgical specimen grew Cladophialophora bantiana. Treatment with terbinaffine post surgery was instituted with no recurrence of the lesion to date. Cutaneous phaeohyphomycosis caused by Cladophialophora bantiana is rare and this case highlights the clinical presentation, laboratory findings and treatment of this infection.


Asunto(s)
Cladosporium/aislamiento & purificación , Dermatomicosis/microbiología , Infecciones Oportunistas/microbiología , Antifúngicos/uso terapéutico , Dermatomicosis/patología , Dermatomicosis/terapia , Diagnóstico Diferencial , Femenino , Humanos , Huésped Inmunocomprometido , Itraconazol/uso terapéutico , Persona de Mediana Edad , Naftalenos/uso terapéutico , Infecciones Oportunistas/patología , Infecciones Oportunistas/terapia , Terbinafina , Resultado del Tratamiento
14.
Br J Dermatol ; 156(3): 480-5, 2007 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-17300237

RESUMEN

BACKGROUND: Sweet's syndrome (SS) is the prototypic neutrophilic dermatosis. First described in 1964, the characterization of new clinical associations, unique histopathological findings and clinical variants have stimulated much interest and discussion recently. However, the prevalence of these unusual variants and clinical associations within a single cohort of patients, has not been described. OBJECTIVES: To describe and evaluate the prevalence of unusual clinical and histopathological features, as well as the clinical associations of SS seen in patients from the National Skin Centre, Singapore. METHODS: This is a retrospective study of all consecutive cases of SS seen at our centre over a 5.5-year period (June 1999-December 2004). Data on associated systemic diseases was obtained from the medical records and matched with information from the National Cancer Registry, Singapore. Patients not actively followed up for more than 3 months were contacted for their updated health status. RESULTS: Thirty-seven patients were identified. Ten (27%) had non-idiopathic SS. These were associated with haematological disorders, connective tissue disorders, infections or a drug. Twenty-nine patients (78%) had at least one atypical clinical or histopathological feature. Atypical clinical features included bullous lesions, SS with hand involvement or neutrophilic dermatoses of the hands and the concomitant existence of subcutaneous SS with pyoderma gangrenosum. SS was the presenting feature in three patients with infections caused by atypical organisms, including Mycobacterium chelonae, Penicillium species and Salmonella type D. Unique histopathological variants included subcutaneous SS and lesions containing an admixture of mature and immature neutrophils. Subcutaneous neutrophilic inflammation seemed to be more common in patients with an underlying haematological disorder. This group of patients also had a lower mean haemoglobin level. CONCLUSIONS: Unusual clinical and histopathological variants of SS described in the literature are similarly encountered in our cohort of patients, with some features being more common than others. We highlight and discuss some unique clinical and histopathological observations seen in our patients with SS.


Asunto(s)
Síndrome de Sweet/diagnóstico , Adolescente , Adulto , Anciano , Antineoplásicos/efectos adversos , Benzamidas , Erupciones por Medicamentos/diagnóstico , Erupciones por Medicamentos/patología , Femenino , Dermatosis de la Mano/diagnóstico , Dermatosis de la Mano/patología , Neoplasias Hematológicas/complicaciones , Humanos , Mesilato de Imatinib , Masculino , Persona de Mediana Edad , Neutrófilos/patología , Piperazinas/efectos adversos , Pirimidinas/efectos adversos , Estudios Retrospectivos , Enfermedades Cutáneas Vesiculoampollosas/diagnóstico , Enfermedades Cutáneas Vesiculoampollosas/patología , Síndrome de Sweet/etiología , Síndrome de Sweet/patología
16.
Singapore Med J ; 48(1): e22-4, 2007 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-17245500

RESUMEN

Trigeminal trophic syndrome (TTS) is an uncommon condition characterised by anaesthesia, paraesthesias and ala nasi ulceration, following peripheral or central damage to the trigeminal nerve. Only about 100 cases have been described in the literature to date. We report a 74-year-old woman who presented with a right cheek ulcer accompanied by pruritus and paraesthesia for three months. An old right cerebellar infarct was demonstrated on magnetic resonance imaging of the brain. Vertebrobasilar insufficiency leading to the cerebellar infarct is likely to have predisposed her to developing TTS. An underlying infectious, malignant and vasculitic cause for the ulcer was excluded by a skin biopsy. An increased awareness of the predisposing factors and clinical presentations of this important disfiguring condition is necessary to ensure prompt diagnosis and treatment.


Asunto(s)
Mejilla , Enfermedades del Nervio Trigémino/complicaciones , Úlcera/etiología , Anciano , Diagnóstico Diferencial , Resultado Fatal , Femenino , Humanos , Imagen por Resonancia Magnética , Síndrome , Enfermedades del Nervio Trigémino/diagnóstico , Úlcera/diagnóstico
17.
Clin Otolaryngol ; 31(5): 399-403, 2006 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-17014449

RESUMEN

OBJECTIVE: There has been a lack of patient-centred evidence in the Otolaryngology literature, that non-laser endonasal dacryocystorhinostomy improves the quality of life of patients. Many studies demonstrate successful outcomes based on non-validated subjective patient reporting. The aim of this survey was to evaluate the impact of non-laser endonasal dacryocystorhinostomy on the quality of life of patients using a validated questionnaire, the Glasgow Benefit Inventory (GBI). DESIGN: Prospective non-randomised case series. SETTING: Secondary otorhinolaryngology-ophthalmology centre, single centre. PARTICIPANTS: Sixty-five consecutive patients undergoing non-laser endonasal dacryocystorhinostomy were asked to complete a questionnaire at their follow-up clinic appointment. All patients had a minimum of 9 months follow-up. MAIN OUTCOME MEASURES: A consultant ophthalmologist reviewed each patient six months after surgery and recorded the outcomes as 'cure', 'better', 'no change' or 'worse'. We defined 'success' as cured or better. 'Failure' suggests no improvement or worsening epiphora. The validated 18-item GBI was used. RESULTS: Fully completed questionnaires were received from 55 patients. Mean total GBI scores were +34 for successful non-laser endonasal dacryocystorhinostomy and -19 for failed non-laser endonasal dacryocystorhinostomy (Mann-Whitney z = 3.8, P < 0.001). CONCLUSION: Successful non-laser endonasal dacryocystorhinostomy does confer significant quality of life improvement.


Asunto(s)
Dacriocistorrinostomía , Calidad de Vida , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Estudios de Seguimiento , Humanos , Terapia por Láser , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Perfil de Impacto de Enfermedad , Encuestas y Cuestionarios , Resultado del Tratamiento , Reino Unido/epidemiología
19.
Br J Ophthalmol ; 88(9): 1197-200, 2004 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-15317715

RESUMEN

BACKGROUND/AIMS: The management of lower eyelid retraction can be challenging, and established techniques to correct it are not always successful. Previous reports have suggested a role for the ultrathin high density porous polyethylene lower eyelid spacer (Medpor LES) in such patients. The authors report the experience of three surgeons implanting Medpor LES over 1 year, and ascertain whether such implants are a safe and effective alternative to autogenous spacers. METHODS: A prospective, interventional, non-comparative case series of consecutive patients. Surgical indications for Medpor LES were noted. Preoperative and postoperative lower marginal reflex distance (L-MRD), vertical palpebral aperture (PA), lagophthalmos, and scleral show inferior to the limbus (LSS) were recorded, together with major and minor complications. RESULTS: 32 patients (35 eyelids) had a Medpor LES inserted, 22/32 under local anaesthetic, and nine with adjunctive procedures. Mean follow up was 22 months (range 15-28 months). The Medpor LES was effective in reducing the palpebral aperture (p<0.001) and lagophthalmos (p = 0.04) and raising the lower eyelid height by reducing both L-MRD (p = 0.006) and LSS (p<0.001). However there were major complications in 7/32 patients and minor complications in 8/32, most requiring further surgery. Final outcome was good in 24/35 eyelids and satisfactory in 5/35. CONCLUSIONS: Despite a good or satisfactory final outcome in the majority of patients, the value of this technique is limited by complications, and should be reserved for those unsuitable for safer techniques.


Asunto(s)
Materiales Biocompatibles/uso terapéutico , Blefaroplastia/métodos , Enfermedades de los Párpados/cirugía , Párpados/cirugía , Polietilenos/uso terapéutico , Implantación de Prótesis/métodos , Adulto , Anciano , Anciano de 80 o más Años , Blefaroplastia/efectos adversos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Resultado del Tratamiento
20.
BMJ ; 311(7013): 1131-5, 1995 Oct 28.
Artículo en Inglés | MEDLINE | ID: mdl-7580708

RESUMEN

OBJECTIVE: To evaluate different methods for community based screening for sight threatening diabetic eye disease. DESIGN: Prospective study. SETTING: Mobile screening unit visiting inner city community clinics; hospital assessment clinic (tertiary centre). SUBJECTS: 395 diabetic patients registered with four general practices in an inner city location. INTERVENTIONS: Community based photography with mydriasis and direct ophthalmoscopy through dilated pupils by an experienced ophthalmologist, both compared with reference standard of slit lamp biomicroscopy by a consultant specialist in medical retinal disease. MAIN OUTCOME MEASURES: Sensitivity and specificity of screening method and prevalence of sight threatening diabetic eye disease (moderate preproliferative retinopathy, circinate maculopathy, exudate within 1 disc diameter of fixation, other diabetes related eye disease). RESULTS: 358 subjects underwent photography, 326 attended hospital clinic for ophthalmoscopy, and six were ungradable on photographs and biomicroscopy, leaving 320 for analysis. Of these 295 (91%) attended clinic within four months of photography. Sensitivity of detection of eye disease by photography was 89% (95% confidence interval 80% to 98%), significantly better than for direct ophthalmoscopy (65% (51% to 79%)). Analysis of patients with false negative results indicated possible improvement of photographic sensitivity to 93% by addition of stereoscopic macular pair photographs. Specificity of detection of sight threatening eye disease was 86% (82% to 90%) for photography and 97% (95% to 99%) for direct ophthalmoscopy. CONCLUSIONS: Since high sensitivity is essential for an effective screening programme, a photographic method should be considered as preferred option in national, community based screening programmes. Even in the hands of an experienced ophthalmologist, direct ophthalmoscopy is limited by weaknesses inherent to the instrument.


Asunto(s)
Oftalmopatías/prevención & control , Oftalmoscopía/normas , Fotograbar/normas , Selección Visual/normas , Atención Ambulatoria/normas , Retinopatía Diabética/prevención & control , Inglaterra , Humanos , Prevalencia , Estudios Prospectivos , Sensibilidad y Especificidad , Salud Urbana , Selección Visual/métodos , Agudeza Visual
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA